Ifosfamide chemotherapy for pancreatic carcinoma
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 18 (2) , S51-S54
- https://doi.org/10.1007/bf00647452
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.1983
- Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.1982
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—IPublished by Elsevier ,1981
- TRIALS OF SINGLE-AGENT AND COMBINATION CHEMOTHERAPY FOR ADVANCED CANCER OF THE PANCREAS1981
- PREVENTION OF ISOPHOSPHAMIDE-INDUCED UROTHELIAL TOXICITY WITH 2-MERCAPTOETHANE SULPHONATE SODIUM (MESNUM) IN PATIENTS WITH ADVANCED CARCINOMAThe Lancet, 1980
- Biology, Diagnosis, and Chemotherapeutic Management of Pancreatic MalignancyPublished by Elsevier ,1977
- Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours.1976
- Unexpected toxicity in patients treated with iphosphamide.1972
- Effects of chlorambucil (NSC-3088) in 374 patients with advanced cancer. Eastern Clinical Drug Evualuation Program.1968
- CyclophosphamideJAMA, 1963